Singapore, Sept. 10 -- Bracco Imaging has expanded its BubbleGen cell selection portfolio with the launch of the BubbleGen CD3+ T Cell Selection Kit, a microbubble-based solution designed to support cell therapy research and manufacturing workflows without the use of magnetic beads.

The launch marks the first expansion of the BubbleGen platform following the introduction of its early access programme in May 2026.

Cell selection is a critical step in cell therapy manufacturing, particularly for programmes involving CAR-T and TCR-T therapies.

Bracco said conventional magnetic bead-based workflows can add complexity, time and cost to manufacturing, particularly as developers look to scale production.

BubbleGen was developed as a non-magn...